Abstract
Optical properties of gold and silver nanoparticles are considered. Processes of preparation of these particles are described. The data presented about application of these nanoparticles in immunoagglutination assays. The features of these metals in immunoagglutination assays are compared. Application of gold nanoparticles in DNA hybridization assays is presented. Application of these metals in cell imaging and therapy is considered. Other prospective metal and semiconductor composites for application in these area are considered.
Current Clinical Pharmacology
Title: Gold and Silver Nanoparticles in Bioassay, Cell Visualization and Therapy
Volume: 4 Issue: 2
Author(s): Vardan K. Gasparyan
Affiliation:
Abstract: Optical properties of gold and silver nanoparticles are considered. Processes of preparation of these particles are described. The data presented about application of these nanoparticles in immunoagglutination assays. The features of these metals in immunoagglutination assays are compared. Application of gold nanoparticles in DNA hybridization assays is presented. Application of these metals in cell imaging and therapy is considered. Other prospective metal and semiconductor composites for application in these area are considered.
Export Options
About this article
Cite this article as:
Gasparyan K. Vardan, Gold and Silver Nanoparticles in Bioassay, Cell Visualization and Therapy, Current Clinical Pharmacology 2009; 4 (2) . https://dx.doi.org/10.2174/157488409788184954
DOI https://dx.doi.org/10.2174/157488409788184954 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Synthesis, In Vitro Anticancer, Anti-Inflammatory and DNA Binding Activity of Thiazolidinedione Derivatives
Anti-Cancer Agents in Medicinal Chemistry Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer
Current Pharmaceutical Design The Association between Tumor-associated Macrophages and Glioblastoma: A Potential Target for Therapy
Current Pharmaceutical Design High Survivin Expression in Ductal Carcinoma In Situ (DCIS): A Potential Therapeutic Target
Current Cancer Therapy Reviews Role of Sequence Variations in <i>AhR</i> Gene Towards Modulating Smoking Induced Lung Cancer Susceptibility in North Indian Population: A Multiple Interaction Analysis
Current Genomics New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments
Mini-Reviews in Medicinal Chemistry Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
Current Pharmaceutical Design Semaphorins at the Interface of Development and Cancer
Current Drug Targets Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews Proteomic Studies Using Microarrays
Current Proteomics PepT1, ASBT-Linked Prodrug Strategy to Improve Oral Bioavailability and Tissue Targeting Distribution
Current Drug Metabolism Synthesis and Anticancer Activity of Some 2-[3/4-(2-Substituted Phenyl-2- oxoethoxy)benzylidene]-6-substituted-2,3-dihydro-1H-inden-1-one Derivatives
Letters in Drug Design & Discovery Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry The Two Faces of Protein Palmitoylation in Islet β-Cell Function: Potential Implications in the Pathophysiology of Islet Metabolic Dysregulation and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Pleiotropic Role of HSF1 in Neoplastic Transformation
Current Cancer Drug Targets Editorial: [Hot Topic: Antidotes and Rescue Therapies]
Current Pharmaceutical Biotechnology Potential Beneficial Effects of Garlic in Oncohematology
Mini-Reviews in Medicinal Chemistry Paeonol, a Powerful Natural Product with Broad Biological Spectra by Inhibiting Inflammatory Pathway
Current Traditional Medicine Synthesis and Biological Evaluation of Novel Thiazol-2yl-amine Derivatives as Potential Anticancer Agents
Letters in Organic Chemistry Developing Phytoestrogens for Breast Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry